Get informed when a big investor buys or sells
+ FollowUndervalued by 42.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $10.94 Billion |
|---|---|
| Enterprise Value | $15.01 Billion |
| Annual dividend | $0.58 |
| Dividend yield | 4.75% |
| Earnings per Share | $0.28 |
| Beta | 0.41 |
| Outstanding Shares | 933,333,332 |
| P/E Ratio | 81.36 |
|---|---|
| PEG | -270.26 |
| Price to Sales | 0.78 |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | 99.92 |
| Enterprise Value to Net Income | 57 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 0.57 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Evonik Industries AG is a holding company, which engages in the manufacture of specialty chemical products. It operates through the following segments: Nutrition and Care, Resource Efficiency, Performance Materials, Services, and Other O...